These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1663912)

  • 1. [Current chemotherapy in urogenital infections. 4: Gyrase inhibitors].
    Hofstetter A
    Fortschr Med; 1991 Dec; 109(36):739. PubMed ID: 1663912
    [No Abstract]   [Full Text] [Related]  

  • 2. [How are quinolones used in clinical practice? Gyrase antagonists from the viewpoint of the hospital pharmacist].
    Schurz JK
    Pharm Unserer Zeit; 2001; 30(5):400-5. PubMed ID: 11575176
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of urogenital trichomoniasis with Fasigyn].
    Dellenbach P; Muller P
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):369-71. PubMed ID: 4681549
    [No Abstract]   [Full Text] [Related]  

  • 4. [Assessment of the genotoxic risk caused by the gyrase inhibitor ofloxacin using sister chromatid exchange rate analysis].
    Kullich W; Brugger P; Klein G
    Wien Med Wochenschr; 1988 Mar; 138(5):107-9. PubMed ID: 2838977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nitroimidazole trichomonacidal preparations in the treatment of anaerobic pelvic infections].
    Presl J
    Cesk Gynekol; 1983 Mar; 48(2):133-4. PubMed ID: 6850883
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current status of drug-resistant bacteria and the treatment of refractory infections].
    Matsuda S
    Sanfujinka No Jissai; 1970 Feb; 19(2):182-91. PubMed ID: 4909406
    [No Abstract]   [Full Text] [Related]  

  • 7. DNA gyrase as a drug target.
    Maxwell A
    Trends Microbiol; 1997 Mar; 5(3):102-9. PubMed ID: 9080608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etiopathogenetic interpretation of urinary tract infections associated with pelvic inflammatory disease and a clinico-therapeutic study of the effects of norfloxacin].
    Surico N; Tavassoli K
    Minerva Ginecol; 1988 Mar; 40(3):183-92. PubMed ID: 3173768
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vibramycin in the treatment of genitourinary tract diseases in women].
    Bulska M; Sternadel Z
    Pol Tyg Lek; 1969 Sep; 24(34):1325-7. PubMed ID: 4900636
    [No Abstract]   [Full Text] [Related]  

  • 10. [How well do gyrase inhibitors work? The pharmacokinetics of quinolones].
    Sörgel F; Bulitta J; Kinzig-Schippers M
    Pharm Unserer Zeit; 2001; 30(5):418-27. PubMed ID: 11575179
    [No Abstract]   [Full Text] [Related]  

  • 11. Testing potential gyrase inhibitors of bacterial DNA gyrase: a comparison of the supercoiling inhibition assay and "cleavable complex" assay.
    Barrett JF; Bernstein JI; Krause HM; Hilliard JJ; Ohemeng KA
    Anal Biochem; 1993 Oct; 214(1):313-7. PubMed ID: 8250240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase II as a target for anticancer chemotherapy.
    Kaufmann SH; Hancock R
    Acta Biochim Pol; 1995; 42(4):381-93. PubMed ID: 8852329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of drug inhibition of DNA gyrase.
    Lewis RJ; Tsai FT; Wigley DB
    Bioessays; 1996 Aug; 18(8):661-71. PubMed ID: 8760340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gyrase inhibitor: central nervous system side effects].
    Schnuch A
    Dtsch Med Wochenschr; 1987 Apr; 112(14):569. PubMed ID: 3030684
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quinolones in the environment: biological breakdown of gyrase inhibitors].
    Wetzstein HG
    Pharm Unserer Zeit; 2001; 30(5):450-7. PubMed ID: 11575183
    [No Abstract]   [Full Text] [Related]  

  • 16. Topoisomerase II inhibitors--teaching old dogs new tricks.
    Sharma S
    Cancer Invest; 2002; 20(4):596-7. PubMed ID: 12094555
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with potassium ampicillin in gynecology and obstetrics].
    Karschnia R; Granitzka S
    Fortschr Med; 1974 Feb; 92(5):205-7. PubMed ID: 4595002
    [No Abstract]   [Full Text] [Related]  

  • 18. [New quinoline chemotherapy. DNA gyrase inhibitors].
    Havlík J; Krcméry V
    Cas Lek Cesk; 1986 Feb; 125(7):211-4. PubMed ID: 3006917
    [No Abstract]   [Full Text] [Related]  

  • 19. DNA topoisomerase II poisons and inhibitors.
    Capranico G; Giaccone G; Zunino F; Garattini S; D'Incalci M
    Cancer Chemother Biol Response Modif; 1997; 17():114-31. PubMed ID: 9551211
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effective microbiologic spectrum of gyrase inhibitors--indications and contraindications].
    Tauchnitz C
    Z Gesamte Inn Med; 1990 Sep; 45(17):509-12. PubMed ID: 1963246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.